This inventor holds 3 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignee: Synapse B.v.. Active years: 2004-2014.
Company Filing History:
Years Active: 2004-2014
Title: The Innovative Contributions of Robert Wagenvoord
Introduction
Robert Wagenvoord is a notable inventor based in Maastricht, Netherlands. He has made significant contributions to the field of medical diagnostics, particularly in the measurement of thrombin activity in blood samples. With a total of 3 patents to his name, his work has the potential to impact both human and animal health.
Latest Patents
Wagenvoord's latest patents include a method for measuring thrombin activity in whole blood. This invention involves a process where a blood sample is contacted with a fluorogenic substrate of thrombin. The method allows for the measurement of thrombin generation by assessing the fluorescence emitted from the sample. Another significant patent focuses on a diagnostic test for determining the concentration of transient proteolytic activity in composite biological media. This method enables real-time monitoring of thrombin activity in blood or plasma, which is crucial for diagnosing various coagulable states.
Career Highlights
Robert Wagenvoord is currently associated with Synapse B.V., where he continues to develop innovative solutions in the field of diagnostics. His expertise in thrombin activity measurement has positioned him as a key figure in advancing medical technology.
Collaborations
Wagenvoord has collaborated with esteemed colleagues such as Hendrik Coenraad Hemker and Suzette L. Beguin. Their combined efforts have contributed to the development of groundbreaking diagnostic methods.
Conclusion
Robert Wagenvoord's innovative work in thrombin activity measurement showcases his dedication to improving medical diagnostics. His patents reflect a commitment to advancing healthcare solutions that can benefit both humans and animals.